Blood gas & electrolyte testing is used in a number of critical care situations. It is considered the most important tool for diagnosis in patients with either respiratory or metabolic abnormalities. The information gained from these analyses can help to determine whether a patient is receiving sufficient respiratory support, or suffering from heavy trauma or acute heart and lung diseases. This knowledge is vital during surgery and a number of other clinical areas, including neonatal and dialysis units.
As a global leader in in vitro diagnostics, Roche is committed to offer point of care (POC) blood gas & electrolyte solutions to aid timely clinical decisions that support better patient outcomes.